Lantern Pharma Inc (LTRN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.81M
Last updated: Nov 17, 2026 at 4:10 PM ET
Lantern Pharma Inc (LTRN) Stock Chart
Lantern Pharma (LTRN) has a latest price of $0.36 on Nov 17, 2026. Its price fell 89.2% over the past 12 months. The month-end price fell 93.5% over the 5 years through Oct 2026, a compound annual decline of 42.2%.
Price Chart
From Jun 2020 to Oct 2026, its highest month-end close was $19.25 in Dec 2020 and its lowest $0.66 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart LTRN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for LTRN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 85.3%, and over 6 months it fell 88.2%. The month-end price fell 73.4% over the 3 years through Oct 2026, a compound annual decline of 35.7%.
| Period | Change |
|---|---|
| 1 month | -43.1% |
| 3 months | -85.3% |
| 6 months | -88.2% |
| 12 months | -89.2% |
| 12 months, with dividends | -89.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -73.4% | -35.7% |
| 5 years | -93.5% | -42.2% |
Price by Year
Its best calendar year was 2025, when the price fell 5.0%, and its weakest was 2021, when it fell 58.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.66 | -78.2% |
| 2025 | $3.03 | -5.0% |
| 2024 | $3.19 | -25.5% |
| 2023 | $4.28 | -29.1% |
| 2022 | $6.04 | -24.3% |
| 2021 | $7.98 | -58.5% |
Trading Range
The price is 60.6% below its 50-day average of $0.93 and 84.1% below its 200-day average of $2.29.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.36 | |
| 50-day average | $0.93 | -60.6% |
| 200-day average | $2.29 | -84.1% |
Price Risk
Over 3 years, its largest fall from a peak was 96.6%.
| Measure | Value |
|---|---|
| 1-year beta | 3.04 |
| Largest fall, 1 year | -91.2% |
| Largest fall, 3 years | -96.6% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About LTRN
What is LTRN's 1-year price change?
Lantern Pharma's price fell 89.2% over the past 12 months. With dividends included, the 12-month total return was -89.2%.
What is LTRN's 5-year price change?
Lantern Pharma's month-end price fell 93.5% over the 5 years through Oct 2026, a compound annual decline of 42.2%. These figures leave out dividends.
What is LTRN's beta?
Lantern Pharma's 1-year beta against the S&P 500 is 3.04, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 91.2%.
Is the LTRN chart free?
Yes. Advanced Charting for LTRN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
LTRN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors